A healthcare company based out of Pennsylvania caused quite the stir on Tuesday after the company announced that it had entered into an exclusive license agreement with Biosion...

To read the full story on AllPennyStocks.com, click here.

Aclaris Therapeutics (NASDAQ:ACRS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Aclaris Therapeutics
Aclaris Therapeutics (NASDAQ:ACRS)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Aclaris Therapeutics